Molecular Determinants of Lung Function Decline: A Multi- Level Analysis of Gene Expression

Area of Science:

• Genomics
• Pulmonary Medicine
• Molecular Biology

Background:

• Chronic obstructive pulmonary disease (COPD) is marked by progressive lung function decline, measured by forced expiratory volume in one second (FEV₁).
• Understanding the genetic basis of FEV₁ decline is crucial for COPD pathophysiology and therapeutic development.
• Gene expression patterns in inflammatory pathways are hypothesized to associate with FEV₁ decline.

Purpose of the Study:

• To investigate the association between gene expression patterns and FEV₁ decline in COPD patients.
• To identify molecular markers and pathways linked to progressive lung function decline.
• To explore potential therapeutic targets for COPD based on genetic findings.

Main Methods:

• Analysis of whole blood RNA-sequencing data from the COPDGene Study at 5 and 10-year visits.
• Assessment of gene expression in cross-sectional, FEV₁ change, and longitudinal analyses.
• Derivation and validation of a 20-gene signature associated with FEV₁ decline in COPDGene and ECLIPSE studies.

Main Results:

• Distinct gene sets were identified across cross-sectional, FEV₁ change, and longitudinal analyses.
• Pathway analysis highlighted oxidative stress and immune processes in longitudinal gene expression.
• A 20-gene signature, with 17 positively and 3 negatively associated genes, significantly correlated with FEV₁-related traits.

Conclusions:

• The study identified novel molecular markers associated with FEV₁ decline in COPD.
• Findings provide insights into the underlying pathophysiology of COPD.
• Identified gene signatures may represent potential therapeutic targets for COPD intervention.